Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Global Transplant Diagnostic Market: Global Industry Analysis, Industry Outlook and Strategies to 2022

Transplant Diagnostic industry is expected to grow with a CAGR of 9.12% during 2016-2022.
Credence Research | 27.12.2016

According to a recently published report, the global Transplant Diagnostic industry is expected to grow with a CAGR of 9.12% during 2016-2022. The global transplant diagnostic industry is segmented on the basis of application, product, technology, end user, and geography. The report on global transplant diagnostic industry forecast2016-2022 (by application, products, technology, end user, and geography) provides detailed overview and predictive analysis of the industry.
The increasing number of cases of chronic disorders and organ failures, such as- liver, pancreas, lungs, kidney, and heart; in which, the organ has to be relocated or organ transplantation is needed, are driving the transplant diagnostic industry. In addition, increasing investments in R&D in HLA (Human Leukocyte Antigen) typing leading to the development of new and innovative products; and, the growing solid organs, soft tissues, and stem cell transplant procedure are the major drivers that are predicted to boost the global transplant diagnostic industry. Limited medical reimbursements for organ donation and transplantation procedures in many countries is acting as a major restraint for the industry. In the emerging countries, the healthcare infrastructure is improving day by day, creating new growth opportunity for the transplant diagnostic industry.
Full report available global Transplant diagnostic industry forecast 2016-2022 (by application, product, technology, end user, and geography) report at http://www.briskinsights.com/report/transplant-diagnostic-market
The product segment is divided into three sub-segments, among which the software and services sub-segment is displaying the fastest growth in the product segment of global transplant diagnostic industry. Similarly, the end user segment is further divided in four sub-segments, of which the hospitals and transplant centers have dominated the industry in 2014; and, the growth of this industry is attributed to the rising demand of organ transplants.
Geographically, North America had the dominant industry share in 2014. And, as the healthcare industry in the region is increasing continuously, along with the patient’s affordability the industry of North America is expected to continue to lead the global transplant diagnostic industry. Asia Pacific is the fastest growing region during the forecast period, because of the huge potential of the industry with increasing awareness and affordability of expensive medical treatments due to increasing disposable per capita income.
Scope of the Report
1. Global Transplant Diagnostic industry by Application 2012-2022 ($ Million)
1.1. Diagnostic Applications
1.2. Research Applications
2. Global Transplant Diagnostic industry by Products & Services 2012-2022 ($ Million)
2.1. Reagents and Consumables
2.2. Instruments
2.3. Software and Services
3. Global Transplant Diagnostic industry by Technology 2012-2022 ($ Million)
3.1. Molecular Assays
3.1.1. PCR-Based Molecular Assays
3.1.1.1. Sequence-Specific Primer (SSP)-PCR
3.1.1.2. Sequence-Specific Oligonucleotide (SSO)-PCR
3.1.2. Sequencing-Based Molecular Assay
3.1.2.1. Sanger Sequencing
3.1.2.2. Next-Generation Sequencing (NGS)
3.2. Non-Molecular Assay
3.2.1. Serological Assay
3.2.2. Mixed Lymphocyte Culture (MLC) Assay
4. Global Transplant Diagnostic industry by End User2012-2022 ($ Million)
4.1. Hospitals and Transplant Centers
4.2. Commercial Service Providers
4.3. Research Laboratories and Academic Institutes
5. Global Transplant Diagnostic industry Regional Outlook 2012-2022($ Million)
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Rest of the world
6. Company Profiles
6.1. Abbott laboratories, Inc. (U.S.)
6.2. Ad Sigma-Aldrich
6.3. Affymetrix, Inc. (U.S.)
6.4. Bio-Rad Laboratories, Inc. (U.S.)
6.5. F. Hoffmann-La-Roche Limited. (Switzerland)
6.6. Illumina, Inc. (U.S.)
6.7. Immucor, Inc. (U.S)
6.8. Linkage Biosciences
6.9. Luminex Corporation. (U.S.)
6.10. Olerup SSP AB (Sweden)
6.11. Qiagen N.V. (Netherlands)
Request Free Sample: http://www.briskinsights.com/sample-request/254
Full report available global Transplant diagnostic industry forecast 2016-2022 (by application, product, technology, end user, and geography) report at http://www.briskinsights.com/report/transplant-diagnostic-market
Related Reports:
http://www.briskinsights.com/report/reprocessed-medical-devices-market
http://www.briskinsights.com/report/intrapartum-monitors-market
http://www.briskinsights.com/report/intrapartum-monitors-market
About Us:
Brisk Insights is a global Industry research firm. Our insightful analysis is focused on developed and emerging Industrys. We identify trends and forecast Industrys with a view to aid businesses identify Industry opportunities optimize strategies. Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of Industry information. Our Research and data analysis is an efficient and cost-effective way of providing robust Industry analysis and can yield highly valuable intelligence relating to consumers, competitors and Industrys.
Contact Us:
Jennifer Smith
Office 1094
109 Vernon House
Friar Lane, Nottingham
NG16DQ, United Kingdom
Phone: +448081890034 (UK)
Email: sales@briskinsights.com
Website: http://www.briskinsights.com/

Img of Credence Research
About the tenderer: Credence Research

Working in a highly dynamic and multi-dimensional business makes decision making complex.